本页面由Tiger Trade Technology Pte. Ltd.提供服务

美第奇新星生物技术

1.51
-0.0310-2.01%
成交量:1.80万
成交额:2.74万
市值:7,416.17万
市盈率:-6.90
高:1.56
开:1.56
低:1.50
收:1.54
52周最高:3.90
52周最低:1.17
股本:4,914.62万
流通股本:4,349.65万
量比:0.42
换手率:0.04%
股息:- -
股息率:- -
每股收益(TTM):-0.2188
每股收益(LYR):-0.2445
净资产收益率:-25.56%
总资产收益率:-16.41%
市净率:1.99
市盈率(LYR):-6.17

数据加载中...

2024/08/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/06/12

重要事件披露

Form 8-K - Current report
2024/05/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/04/01

重要事件披露

Form 8-K - Current report
2024/02/15

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/01/20

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/01/20

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/01/20

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/01/19

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2023/11/10

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/10

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/07

重要事件披露

Form 8-K - Current report
2023/06/22

重要事件披露

Form 8-K - Current report
2023/06/14

重要事件披露

Form 8-K - Current report
2023/05/11

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/04/26

重要事件披露

8-K - Current report
2023/03/28

[修订]年度报告

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/02/16

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/11/10

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/09/01

SEC问询函

CORRESP [Cover] - Correspondence